Nu Skin Enterprises (NUS) Earnings Analysis

Nu Skin Enterprises (NUS) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it missed with EPS 0.14 USD vs 0.15 USD est (-6.7%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 4.67.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NUS next report earnings?

No confirmed upcoming earnings date is currently scheduled for NUS. This page updates as the calendar is published.

NUS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-070.14 USD0.15 USD-6.7%Miss
2026-02-120.29 USD0.3 USD-3.3%Miss
2025-11-060.34 USD0.3 USD+13.3%Beat
2025-08-070.43 USD0.25 USD+72%Beat
2025-05-080.23 USD0.15 USD+53.3%Beat
2025-02-130.38 USD0.24 USD+58.3%Beat

Beat rate: 4/6 (67%) over reported quarters with consensus data.

NUS valuation and analyst view

Trailing P/E4.67
Trailing EPS1.131 USD
Price / book0.32
Dividend yield4.60%
Market cap0.26B
Analyst consensusHold (0 buy / 10 hold / 1 sell)

Related research pages

Frequently asked questions

When is Nu Skin Enterprises (NUS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for NUS. This page updates as the calendar is published.

Did NUS beat earnings last quarter?

In its 2026-05-07 report, NUS posted EPS of 0.14 USD versus a 0.15 USD estimate — a miss of 6.7%.

What is NUS's earnings track record?

Over the last 6 reported quarters with consensus data, NUS beat estimates 4 times (67%).

What is NUS's current P/E ratio and EPS?

NUS trades at a trailing P/E of 4.67 on trailing EPS of 1.1311771295796855 USD.

What do analysts rate NUS?

Analyst consensus is "Hold" across 11 ratings (0 strong buy, 0 buy, 10 hold, 1 sell, 0 strong sell).